CD11b immunophenotyping identifies inflammatory profiles in the mouse and human lungs

Mucosal Immunology

Volumn 9, Issue 2, 2016, Pages 550-563

  Duan, M ^a,b,c,d   Steinfort, D P ^e   Smallwood, D ^e   Hew, M ^f   Chen, W ^g   Ernst, M ^b,c,g   Irving, L B ^e   Anderson, G P ^b   Hibbs, M L ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c OLIVIA NEWTON JOHN CANCER RESEARCH INSTITUTE   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f ALFRED HOSPITAL   (Australia)

^g WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; ENDOTOXIN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; BIOLOGICAL MARKER; INPP5D PROTEIN, MOUSE; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 5 PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EOSINOPHILIA; FLOW CYTOMETRY; GENETIC MODEL; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MICROENVIRONMENT; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STANDARDIZATION; UPREGULATION; ANIMAL; ASTHMA; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; MACROPHAGE ACTIVATION; METABOLISM; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EOSINOPHILIA;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD11B; ASTHMA; BIOMARKERS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE 5-PHOSPHATASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EOSINOPHILIA;

EID: 84961820406     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.84     Document Type: Article

References (49)

1. Betts M.R, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 107, 4781-4789 (2006).
2. Ghia P, et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood. 101, 1262-1269 (2003).
3. Kok A, et al. Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. Mucosal. Immunol. 8, 127-140 (2015).
4. Geissmann F, Jung S, & Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19, 71-82 (2003).
5. Murray P.J, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 41, 14-20 (2014).
6. Lotvall J, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J. Allergy. Clin. Immunol. 127, 355-360 (2011).
7. Moore W.C, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 181, 315-323 (2010).
8. Thomsen M, Dahl M, Lange P, Vestbo J, & Nordestgaard B.G. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186, 982-988 (2012).
9. Agusti A, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 7, e37483 (2012).
10. Hurst J.R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 363, 1128-1138 (2010).
11. Kasahara Y, Tuder R.M, Cool C.D, Lynch D.A, Flores S.C, & Voelkel N.F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163, 737-744 (2001).
12. Morris D.G, et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature. 422, 169-173 (2003).
13. Shibata Y, Zsengeller Z, Otake K, Palaniyar N, & Trapnell B.C. Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema. Blood. 98, 2845-2852 (2001).
14. Oh S.Y, et al. Src homology 2 domain-containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung. J. Allergy Clin. Immunol. 119, 123-131 (2007).
15. Duan M, Li, W.C, Vlahos, R., Maxwell M.J, Anderson G.P.&Hibbs, M.L. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J. Immunol. 189, 946-955 (2012).
16. Helgason C.D, et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12, 1610-1620 (1998).
17. Rauh M.J, et al. SHIP represses the generation of alternatively activated macrophages. Immunity. 23, 361-374 (2005).
18. Harder K.W, et al. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood. 104, 3901-3910 (2004).
19. Takeshita S, et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8, 943-949 (2002).
20. Maxwell M.J, Duan M, Armes J.E, Anderson G.P, Tarlinton D.M, & Hibbs M.L. Genetic segregation of inflammatory lung disease and autoimmune disease severity in SHIP-1-/- mice. J. Immunol. 186, 7164-7175 (2011).
21. Sly L.M, Rauh, M.J, Kalesnikoff J, Song C.H. &Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity. 21, 227-239 (2004).
22. Ernst M, et al. Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J. Exp. Med. 196, 589-604 (2002).
23. Johnston L.K, Rims C.R, Gill S.E, McGuire J.K, & Manicone A.M. Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am. J. Respir. Cell Mol. Biol. 47, 417-426 (2012).
24. Stevens W.W, Kim T.S, Pujanauski L.M, Hao X, & Braciale T.J. Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J. Immunol. Methods. 327, 63-74 (2007).
25. Mallia P, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am. J. Respir. Crit. Care Med. 183, 734-742 (2011).
26. Aaron S.D, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 349-355 (2001).
27. Bafadhel M, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am. J. Respir. Crit. Care Med. 184, 662-671 (2011).
28. Tanimoto M, Scheinberg D.A, Cordon-Cardo C, Huie D, Clarkson B.D, & Old L.J. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195. Leukemia. 3, 339-348 (1989).
29. Hussell T, & Bell T.J. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14, 81-93 (2014).
30. Xue J, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 40, 274-288 (2014).
31. Sans-Fons M.G, et al. Arginine transport is impaired in C57Bl/6 mouse macrophages as a result of a deletion in the promoter of Slc7a2 (CAT2), and susceptibility to Leishmania infection is reduced. J. Infect. Dis. 207, 1684-1693 (2013).
32. Schneemann M, & Schoedon G. Species differences in macrophage NO production are important. Nat. Immunol. 3, 102-102 (2002).
33. Gautier E.L, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118-1128 (2012).
34. Chiu I.M, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4, 385-401 (2013).
35. Dutta P, et al. Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J. Exp. Med. 212, 497-512 (2015).
36. Palecanda A, et al. Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J. Exp.Med. 189, 1497-1506 (1999).
37. Misharin A.V, Morales-Nebreda L, Mutlu G.M, Budinger G.R, & Perlman H. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am. J. Respir. Cell Mol. Biol. 49, 503-510 (2013).
38. Kaku Y, et al. Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease. PLoS One. 9, e87400 (2014).
39. Oshansky C.M, et al. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. Am. J. Respir. Crit. Care Med. 189, 449-462 (2014).
40. Corbi A.L, Kishimoto T.K, Miller L.J, & Springer T.A. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type. 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J. Biol. Chem. 263, 12403-12411 (1988).
41. Anderson D.C, & Springer T.A. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150, 95 glycoproteins. Annu. Rev. Med. 38, 175-194 (1987).
42. Vedder N.B, & Harlan J.M. Increased surface expression ofCD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J. Clin. Invest. 81, 676-682 (1988).
43. Lu H, et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest. 99, 1340-1350 (1997).
44. Hirahashi J, et al. Mac-1 signaling via Src-family and Syk kinases results in elastase-dependent thrombohemorrhagic vasculopathy. Immunity. 25, 271-283 (2006).
45. Rosseau S, et al. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L25-L35 (2000).
46. Buhling F, et al. MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia. Immunol. Lett. 71, 185-190 (2000).
47. Lofdahl J.M, Wahlstrom J, & Skold C.M. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin. Exp. Immunol. 145, 428-437 (2006).
48. Ueno M, et al. Alendronate inhalation ameliorates elastase-induced pulmonary emphysema in mice by induction of apoptosis of alveolar macrophages. Nat. Commun. 6, 6332 (2015).
49. Maecker H.T, McCoy J.P, & Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat. Rev. Immunol. 12, 191-200 (2012).